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Aims: The present study aimed to explore possible effects of endothelin-1 (ET-1) on ß2-adrenoceptor gene
transcription in human lung ﬁbroblasts.
Main methods: MRC-5 human lung ﬁbroblasts were cultured in absence or presence of test substances, fol-
lowed by ß2-adrenoceptor mRNA determination by quantitative real time PCR.
Key ﬁndings: ET-1 caused a marked and rapid in onset (1 hr) increase in β2-adrenoceptor mRNA, an effect ad-
ditive to that of short time (1 hr) exposure to the β2-adrenoceptor agonist olodaterol. The stimulatory effect
of ET-1 on β2-adrenoceptor mRNA was prevented by the non-selective ET-A/ET-B receptor antagonist bosen-
tan, indicating that it was mediated via speciﬁc ET receptors. In the presence of actinomycin D the effect of
ET-1 was prevented indicating that ET-1 acts via increased transcription of the β2-adrenoceptor gene. ET-
1-induced up-regulation of β2-adrenoceptor mRNA was also seen in the presence of cycloheximide excluding
indirect effects via up-regulation of other regulatory proteins.
Conclusions: ET-1 can up-regulate β-adrenoceptor gene transcription in human lung ﬁbroblasts.© 2012 Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Endothelin-1 (ET-1) is a potent constrictor of vascular and airway of
smoothmuscle and appears to exert in addition various pro-ﬁbrotic and
pro-inﬂammatory effects. Its role in the pathophysiology of pulmonary
hypertension is well documented (for review see Shao et al., 2011), but
in addition there is increasing evidence that ET-1may also participate in
the pathogenesis of pulmonary ﬁbrosis and obstructive airway disease
(e.g. Chalmers et al., 1997; Goldie and Henry, 1999; Polikepahad et al.,
2006; Ross et al., 2010; Swigris and Brown, 2010). Human lung ﬁbro-
blasts express ET-1 as well as its receptors, and ET-1 has been shown
to stimulate various pro-ﬁbrotic processes, such ﬁbroblast proliferation,
collagen synthesis and myo-ﬁbroblast differentiation (Ahmedat et al.,
2010a,b; Gallelli et al., 2005).
Based on their bronchodilatory effects, β2-adrenergic agonists
constitute an essential element in the treatment of bronchial asthma
and COPD (e.g. Barnes, 2004; Fitzgerald and Fox, 2007; Sin et al.,
2003; Walters et al., 2005). However, there is substantial evidence
that they may exert a number of additional effects of potential thera-
peutic value. Thus, we recently showed that human lung ﬁbroblasts
express β2-adrenoceptors whichmediate inhibitory effects on various
pro-ﬁbrotic features (Lamyel et al., 2011) and ET-1 expression (Racké
et al., 2011b). The expression of β2-adrenoceptors in human lungy & Toxicology, University of
05 Bonn, Germany. Tel.: +49
-NC-ND license.ﬁbroblasts appears to be highly regulated at the level of mRNA; for
example, corticosteroids cause a marked up- and TGF-β a marked
down-regulation and β2-adrenergic agonists exert in a time-
dependent manner opposing effects (Racké et al., 2011a; Warnken-
Uhlich et al., 2011).
The present study aimed to explore potential effects of ET-1 on β2-
adrenoceptor mRNA expression in human lung ﬁbroblasts.
Materials and methods
Culture of lung ﬁbroblasts
MCR-5 human lung ﬁbroblasts (CCL-171, ATCC, Manassas, USA)
were grown in Eagle's MEM supplemented with 10% FCS, 2 mM L-
glutamine, Earle's BBS adjusted to contain 2.2 g/l sodium bicarbonate,
0.1 mM non-essential amino acids, 1.0 mM sodium pyruvate, 100 U/ml
penicillin and100 μg/ml streptomycin. Cellswere grown in a humidiﬁed
incubator at 37 °C and 5% CO2, and passaged by trypsinization at nearly
conﬂuence.
Extraction of RNA and real time reverse transcription-polymerase chain
reaction
Total RNA was isolated by help of silica-gel-based membranes
according to manufacturer's instructions including an additional
DNase digestion protocol to beware any contamination by genomic
DNA (Qiagen, Hilden, Germany). First strand cDNA was synthesised
using Omniscript reverse transcriptase (Qiagen).
Fig. 1. Effects of short time (1 hr) exposure to ET-1 and/or olodaterol (Olod) in absence
or presence of bosentan (Bos) on β2-adrenoceptor mRNA expression in MRC-5 human
lung ﬁbroblasts. After dissemination, cells were cultured for 24 hr in presence of 10%
FCS followed by 1 hr in FCS-free medium in absence or presence of test drugs at the
concentration indicated. Thereafter, total RNA was isolated, treated with DNase and
used for quantitative real time PCR. Height of columns: β2-adrenoceptor mRNA
(−2ΔΔCt×100) is expressed as % of the respective control of the individual cell
preparation, given are means with S.E.M. of the number of experiments given in the
columns. Signiﬁcance of differences: *Pb0.05; **Pb0.01; ***Pb0.001 vs respective
control; ##Pb0.01 vs respective value in presence of ET-1 or Olod alone; +Pb0.05;
++Pb0.01 vs respective value in absence of Bos.
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of SYBR Green dye on a Statagene Mx3000P real time PCR system. Ap-
plied primer pairs (based on human EMBL sequences) were speciﬁc
for the β2-adrenoceptor 5′-GATTTCAGGATTGCCTTCCAG-3′ and 5′
GTGATATCCACTCTGCTCCCC-3′ and the housekeeping gene GAPDH,
5′-CTGCACCACCAACTGCTTAGC-3′ and 5′-GGCATGGACTGTGGTCAT-
GAG-3′, which was used for normalization. The cycling conditions
were: 10 min polymerase activation at 95 °C and 40 cycles at 95 °C
for 30 sec, 59 °C for 30 sec and 72 °C for 30 sec. The threshold was
automatically set by the software. The crossing point of the ampliﬁca-
tion curve with the threshold represents the ‘Ct’.
Fluorescence data from each sample were analyzed with the
2−[ΔΔCt] method: fold induction=2−[ΔΔCt], where ΔΔCt=[Ct GI (un-
known sample)−Ct GAPDH (unknown sample)]− [Ct GI (calibrator
sample)−Ct GAPDH (calibrator sample)], GI is the gene of interest.
Statistical analysis
All values are means with S.E.M. of n experiments. Normal distri-
bution was conﬁrmed by performing the Kolmogorov–Simirnov test
and in series with n>7 additionally by the D'Agostino–Pearson omni-
bus normality test using Prim5 (GraphPad Software, San Diego, USA).
Statistical signiﬁcance of differences was evaluated by ANOVA or
(when applicable) repeated measures ANOVA followed by Bonferroni
test, again using Prim5.
Drugs and materials
Olodaterol was a gift from Boehringer Ingelheim (Biberach, Germa-
ny) and bosentan from Actelion (Freiburg, Germany). All other drugs
were purchased, actinomycin D, cycloheximide, human endothelin-1,
penicillin-streptomycin solution and trypsin were purchased from
Sigma (Deisenhofen, Germany); desoxynucleotide mixture from Fer-
mentas (St. Leon-Rot, Germany); Eagle's minimal essential medium
(MEM) with Earl's salts and L-glutamine, non-essential amino acids
from PAA (Cölbe, Germany); fetal calf serum (FCS) from Biochrom
(Berlin, Germany); Taq DNA-polymerase from Invitrogen (Karlsruhe,
Germany); Omniscript reverse transcriptase, RNeasy Mini kit, Quanti-
Tect™ SYBR Green PCR kit and RNase-free DNase set from Qiagen (Hil-
den, Germany). Oligodesoxynucleotides for qPCR were obtained from
Euroﬁns MWG Operon (Ebersberg, Germany).
Results
In conﬁrmation of previous observations (Racké et al., 2011a;
Warnken-Uhlich et al., 2011; Kämpfer et al., 2011) the long acting
β2-adrenoceptor agonist olodaterol (Bouyssou et al., 2010) (10 nM,
a maximally effective concentration as previously observed) induced
a rapid (1 hr), but transient increase in β2-adrenoceptor mRNA ex-
pression by about 100% followed by a reduction by about 55% after
4 hr of agonist exposure. ET-1 (10 nM) induced also a rapid (1 hr) in-
crease in β2-adrenoceptor mRNA expression by about 70% and the ef-
fect of ET-1 was at least additive to that of olodaterol, resulting in an
increase by about 210–230% in presence of ET-1 in combination with
olodaterol (Fig. 1A and B). At a higher concentration (100 nM), ET-1
did not show greater effects neither alone nor in combination with
olodaterol (Fig. 1A). The effect of ET-1, both in absence and presence
of olodaterol, was blocked by bosentan, which alone had no effect
(Fig. 1B).
In contrast to the effect of the β-adrenoceptor agonist, that of ET-1
was preserved after 4 hr of exposure, although somewhat smaller in
magnitude, and ET-1 signiﬁcantly opposed the down-regulation
of β2-adrenoceptor mRNA caused by the β-adrenoceptor agonist
(Fig. 2A). As already reported previously (Racké et al., 2011a;
Warnken-Uhlich et al., 2011; Kämpfer et al., 2011), inhibition of de-
novo protein synthesis by cycloheximide caused an about 6-foldincrease in β2-adrenoceptor mRNA (Fig. 2B). Moreover, the down-
regulation caused by 4 hr exposure to olodaterol was prevented by
cycloheximide and converted into a marked additional up-
regulation, resulting in an about 12-fold increase in β2-adrenoceptor
mRNA in the presence of olodaterol and cycloheximide (Fig. 2B).
The effect of ET-1 was also seen in the presence of cycloheximide,
resulting also in about a 9-fold increase in β2-adrenoceptor mRNA
in the presence of ET-1 and cycloheximide (Fig. 2B). The strong stim-
ulatory effects of the β-adrenoceptor agonist and of ET-1 in presence
of cycloheximide were still additive (Fig. 2B). Like the stimulatory ef-
fect of ß-agonists (Racké et al., 2011a; Warnken-Uhlich et al., 2011;
Kämpfer et al., 2011) that of ET-1 was prevented by inhibition of
RNA synthesis by actinomycin D. After 100 min incubation with acti-
nomycin (30 μM) β2-adrenoceptor mRNA was reduced to 34.6±5.7%
of controls (n=7, Pb0.001 vs controls) and by 33.4±4.8% in experi-
ments in which ET-1 (10 nM) was additionally present for the last
60 min (n=7; not signiﬁcantly different vs actinomycin alone).
Discussion
In previous studies we observed that MRC-5 and primary human
lung cells are very similar with regard to the expression pattern of
Fig. 2. Effects of 4-hr exposure to ET-1 and/or olodaterol (Olod) on β2-adrenoceptor
mRNA expression in MRC-5 human lung ﬁbroblasts. After dissemination, cells were
cultured for 24 hr in the presence of 10% FCS followed by 4 hr in FCS-free medium in
absence or presence of test drugs at the concentration indicated, cycloheximide
being present already 30 min prior. Thereafter, total RNA was isolated, treated with
DNase and used for quantitative real time PCR. Height of columns: β2-adrenoceptor
mRNA (−2ΔΔCt×100) is expressed as % of the respective control of the individual
cell preparation, given are means with S.E.M. of the number of experiments given in
the columns. Signiﬁcance of differences: *Pb0.05; ***Pb0.001 vs respective control;
+b0.05; +++b0.01 vs respective value in presence of cycloheximide alone;
#b0.05; #b0.01 vs respective Olod value alone.
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(Haag et al., 2008a,b; Matthiesen et al., 2006) and so far studied
cAMP-mediated signal transduction mechanisms (Haag et al.,
2008b). Furthermore, and of particular importance for the present
study, MRC-5 and primary human lung cells showed the same ex-
pression pattern of β-adrenoceptor subtypes, solely the β2-adreno-
ceptor, and the same functional response upon β-adrenoceptor
activation (Lamyel et al., 2011). Therefore, MRC-5 cells were used in
the present study as a cell line which has been proven to allow to
study physiologically relevant β-adrenergic regulatory mechanisms
in human lung ﬁbroblasts.
The expression of β2-adrenoceptors in human lung ﬁbroblasts ap-
pears to be highly regulated at the transcriptional level. Thus, the half
life of β2-adrenoceptor mRNA was about 25 min (Racké et al., 2011a;
Warnken-Uhlich et al., 2011) indicating a relatively high turnover rate
resulting in close relation between mRNA levels and β2-adrenoceptor
gene transcription, and in line with this conclusion, marked changes
in β2-adrenoceptor mRNA levels were seen for example after short
time exposure to corticosteroids, TGF-β or β-adrenoceptor agonists.
The present experiments show that ET-1 is a further mediator involvedin the regulation of β2-adrenoceptor expression in human lung ﬁbro-
blasts. ET-1 caused a rapid increase in β2-adrenoceptor mRNA which
was prevented by the non-selective ET-A/ET-B receptor antagonist
bosentan, indicating a speciﬁc ET receptor mediated effect. Interesting-
ly, the stimulatory effect of ET-1was additive to that of short time expo-
sure to a β-adrenoceptor agonist. In general, β-adrenoceptors couple
via Gs to adenylyl cyclase and direct activation of adenylyl cyclase by
forskolin mimicked the stimulatory effect of β-adrenoceptor activation
(Racké et al., 2011a;Warnken-Uhlich et al., 2011; Kämpfer et al., 2011).
On the other hand, ET receptors are able to couple in addition to various
other G proteins including Gq/11 and Gi/o (Henry and Goldie, 2001).
Since the effect of forskolin and β-adrenoceptor agonists was not
additive (Kämpfer et al., 2011), the additivity of the effect of ET-1 and
the β-adrenoceptor agonist suggests that ET-1 may cause the up-
regulation of the β2-adrenoceptor expression via a signaling pathway
different from the Gs–adenylyl cyclase pathway. The fact that actinomy-
cin D prevented the up-regulation by ET-1 indicates that an increased
transcription of the β-adrenoceptor gene might be responsible for the
enhanced mRNA levels. Furthermore, the rapid onset of the ET-1 effect
and the observation that ET-1 caused an up-regulation also in the pres-
ence of cycloheximide support the conclusion that the up-regulation of
β-adrenoceptor mRNA expression by ET-1 is the result of a direct stim-
ulation of β-adrenoceptor gene transcription and does not involve the
up-regulation of other regulatory proteins. Whereas the direct stimula-
tory effect ofβ-adrenoceptor–cAMPpathway onβ-adrenoceptormRNA
was transient because of delayed up-regulated inhibitory proteins, the
stimulatory effect of ET-1 was more prolonged and ET-1 was able to
oppose the delayed down-regulation of β-adrenoceptor mRNA follow-
ing β-adrenoceptor agonist exposure.
Receptor desensitization following prolonged agonist exposure is
a generally occurring phenomenon that is also seen for β2-adrenocep-
tors (for review see Shore and Moore, 2003; Johnson, 2006). Howev-
er, several mechanisms appear to exist by which an agonist-induced
down-regulation and loss of function of β2-adrenoceptors may
be limited. Thus, corticosteroids have been shown to stimulate β2-
adrenoceptor expression (Mak et al., 1995; Racké et al., 2011a) and
to reverse agonist induced β2-adrenoceptor tolerance (e.g. Cooper
and Panettieri, 2008). The present observations suggest that endothe-
linergic stimulation of β2-adrenoceptor expression is a further mech-
anism that could contribute to maintenance of β2-adrenoceptor
function during prolonged agonist exposure.
Conclusion
In human lung ﬁbroblasts ET-1 mediates up-regulation of β-
adrenoceptor gene transcription. Whether ET-1 exerts similar effects
in other cells such as airway smooth muscle and whether ET-1 might
be able to enhance β-adrenoceptor function and/or to oppose
agonist-induced loss of β-adrenoceptor function, are important ques-
tions, which have to be addressed in future studies.
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